New York S00987 aims to ensure patient access to FDA-approved abuse-deterrent opioid medications to combat opioid abuse.

New York S00987 amends the public health law and the insurance law to facilitate patient access to abuse-deterrent opioid medications. The bill mandates that insurance carriers and health plans cover at least one abuse-deterrent opioid analgesic drug product per active ingredient. It prohibits prior authorization requirements or service denials that mandate the use of non-abuse-deterrent opioids before accessing abuse-deterrent ones. Additionally, it ensures that cost-sharing for abuse-deterrent opioids does not exceed that for non-abuse-deterrent opioids.

New York S00987 aims to ensure patient access to FDA-approved abuse-deterrent opioid medications to combat opioid abuse.

New York S00987 amends the public health law and the insurance law to facilitate patient access to abuse-deterrent opioid medications. The bill mandates that insurance carriers and health plans cover at least one abuse-deterrent opioid analgesic drug product per active ingredient. It prohibits prior authorization requirements or service denials that mandate the use of non-abuse-deterrent opioids before accessing abuse-deterrent ones. Additionally, it ensures that cost-sharing for abuse-deterrent opioids does not exceed that for non-abuse-deterrent opioids.